158 related articles for article (PubMed ID: 34449914)
1. Curcumin-coated gold nanoparticles attenuate doxorubicin-induced cardiotoxicity via regulating apoptosis in a mouse model.
Sharifiaghdam Z; Dalouchi F; Sharifiaghdam M; Shaabani E; Ramezani F; Nikbakht F; Azizi Y
Clin Exp Pharmacol Physiol; 2022 Jan; 49(1):70-83. PubMed ID: 34449914
[TBL] [Abstract][Full Text] [Related]
2. Curcumin attenuates doxorubicin-induced cardiotoxicity via suppressing oxidative stress and preventing mitochondrial dysfunction mediated by 14-3-3γ.
He H; Luo Y; Qiao Y; Zhang Z; Yin D; Yao J; You J; He M
Food Funct; 2018 Aug; 9(8):4404-4418. PubMed ID: 30063064
[TBL] [Abstract][Full Text] [Related]
3. Apigenin-coated gold nanoparticles as a cardioprotective strategy against doxorubicin-induced cardiotoxicity in male rats via reducing apoptosis.
Sharifiaghdam Z; Amini SM; Dalouchi F; Behrooz AB; Azizi Y
Heliyon; 2023 Mar; 9(3):e14024. PubMed ID: 36915508
[TBL] [Abstract][Full Text] [Related]
4. Doxorubicin and curcumin co-delivery by lipid nanoparticles for enhanced treatment of diethylnitrosamine-induced hepatocellular carcinoma in mice.
Zhao X; Chen Q; Li Y; Tang H; Liu W; Yang X
Eur J Pharm Biopharm; 2015 Jun; 93():27-36. PubMed ID: 25770771
[TBL] [Abstract][Full Text] [Related]
5. Tuftsin-Bearing Liposomes Co-Encapsulated with Doxorubicin and Curcumin Efficiently Inhibit EAC Tumor Growth in Mice.
Murugesan K; Srinivasan P; Mahadeva R; Gupta CM; Haq W
Int J Nanomedicine; 2020; 15():10547-10559. PubMed ID: 33414637
[TBL] [Abstract][Full Text] [Related]
6. Protective effect of curcumin nanoparticles against cardiotoxicity induced by doxorubicin in rat.
Mohammed HS; Hosny EN; Khadrawy YA; Magdy M; Attia YS; Sayed OA; AbdElaal M
Biochim Biophys Acta Mol Basis Dis; 2020 May; 1866(5):165665. PubMed ID: 31918005
[TBL] [Abstract][Full Text] [Related]
7. Curcumin suppresses doxorubicin-induced cardiomyocyte pyroptosis via a PI3K/Akt/mTOR-dependent manner.
Yu W; Qin X; Zhang Y; Qiu P; Wang L; Zha W; Ren J
Cardiovasc Diagn Ther; 2020 Aug; 10(4):752-769. PubMed ID: 32968631
[TBL] [Abstract][Full Text] [Related]
8. Toxicity Reduction and Efficacy Promotion of Doxorubicin in the Treatment of Breast Tumors Assisted by Enhanced Oral Absorption of Curcumin-Loaded Lipid-Polyester Mixed Nanoparticles.
Wang N; Zhang Y; Liu H; Wang A; Ren T; Gou J; Zhang Y; Yin T; He H; Tang X
Mol Pharm; 2020 Dec; 17(12):4533-4547. PubMed ID: 33201717
[TBL] [Abstract][Full Text] [Related]
9. A complex micellar system co-delivering curcumin with doxorubicin against cardiotoxicity and tumor growth.
Zhang D; Xu Q; Wang N; Yang Y; Liu J; Yu G; Yang X; Xu H; Wang H
Int J Nanomedicine; 2018; 13():4549-4561. PubMed ID: 30127606
[TBL] [Abstract][Full Text] [Related]
10. Enhanced 4T1 breast carcinoma anticancer activity by co-delivery of doxorubicin and curcumin with core-shell drug-carrier based on heparin modified poly(L-lactide) grafted polyethylenimine cationic nanoparticles.
Guo O; Li X; Yang Y; Wei J; Zhao Q; Luo F; Qian Z
J Biomed Nanotechnol; 2014 Feb; 10(2):227-37. PubMed ID: 24738331
[TBL] [Abstract][Full Text] [Related]
11. Glycyrrhizin improved autophagy flux via HMGB1-dependent Akt/mTOR signaling pathway to prevent Doxorubicin-induced cardiotoxicity.
Lv X; Zhu Y; Deng Y; Zhang S; Zhang Q; Zhao B; Li G
Toxicology; 2020 Aug; 441():152508. PubMed ID: 32525084
[TBL] [Abstract][Full Text] [Related]
12. Co-delivery of Doxorubicin and Curcumin with Polypeptide Nanocarrier for Synergistic Lymphoma Therapy.
Guo W; Song Y; Song W; Liu Y; Liu Z; Zhang D; Tang Z; Bai O
Sci Rep; 2020 May; 10(1):7832. PubMed ID: 32398729
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and
Pandey M; Singh AK; Pandey PC
J Mater Chem B; 2023 Mar; 11(13):3014-3026. PubMed ID: 36938847
[TBL] [Abstract][Full Text] [Related]
14. Adiponectin agonist ADP355 ameliorates doxorubicin-induced cardiotoxicity by decreasing cardiomyocyte apoptosis and oxidative stress.
Zhao D; Xue C; Li J; Feng K; Zeng P; Chen Y; Duan Y; Zhang S; Li X; Han J; Yang X
Biochem Biophys Res Commun; 2020 Dec; 533(3):304-312. PubMed ID: 32958254
[TBL] [Abstract][Full Text] [Related]
15. Codelivery of doxorubicin and curcumin with lipid nanoparticles results in improved efficacy of chemotherapy in liver cancer.
Zhao X; Chen Q; Liu W; Li Y; Tang H; Liu X; Yang X
Int J Nanomedicine; 2015; 10():257-70. PubMed ID: 25565818
[TBL] [Abstract][Full Text] [Related]
16. Immobilization of gold nanoparticles on folate-conjugated dendritic mesoporous silica-coated reduced graphene oxide nanosheets: a new nanoplatform for curcumin pH-controlled and targeted delivery.
Malekmohammadi S; Hadadzadeh H; Farrokhpour H; Amirghofran Z
Soft Matter; 2018 Mar; 14(12):2400-2410. PubMed ID: 29512668
[TBL] [Abstract][Full Text] [Related]
17. Reversion of multidrug resistance by co-encapsulation of doxorubicin and curcumin in chitosan/poly(butyl cyanoacrylate) nanoparticles.
Duan J; Mansour HM; Zhang Y; Deng X; Chen Y; Wang J; Pan Y; Zhao J
Int J Pharm; 2012 Apr; 426(1-2):193-201. PubMed ID: 22274587
[TBL] [Abstract][Full Text] [Related]
18. Plasmonic hyperthermia or radiofrequency electric field hyperthermia of cancerous cells through green-synthesized curcumin-coated gold nanoparticles.
Rezaeian A; Amini SM; Najafabadi MRH; Farsangi ZJ; Samadian H
Lasers Med Sci; 2022 Mar; 37(2):1333-1341. PubMed ID: 34406533
[TBL] [Abstract][Full Text] [Related]
19. Resolvin E1 protects against doxorubicin-induced cardiotoxicity by inhibiting oxidative stress, autophagy and apoptosis by targeting AKT/mTOR signaling.
Zhang J; Wang M; Ding W; Zhao M; Ye J; Xu Y; Wang Z; Ye D; Li D; Liu J; Wan J
Biochem Pharmacol; 2020 Oct; 180():114188. PubMed ID: 32750329
[TBL] [Abstract][Full Text] [Related]
20. Assessment of herb-drug synergy to combat doxorubicin induced cardiotoxicity.
Jain A; Rani V
Life Sci; 2018 Jul; 205():97-106. PubMed ID: 29752960
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
